Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2012

Feb 22, 2012

30291_dirs_2012-02-22_7510ae69-b2c9-4e75-a1d0-edc204b02836.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-07-15

Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-07-15 Common Stock F 8791 $104.00 Disposed 54374 Direct

Footnotes

F1: This amendment is being filed to correct a transaction date that was incorrectly stated as 07/14/2011 in the original Form 4 filied on 07/19/2011.